ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 783

$1.13M Total Retail Price of All Prescriptions

Rank: 35 out of 783

598 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 598 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

24% of this provider’s 598 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 12,197 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 797 446 S3 1 2
FUROSEMIDE 683 474 2 7
LEVOTHYROXINE SODIUM 618 409 3 1
AMLODIPINE BESYLATE 582 389 4 5
LISINOPRIL 517 391 5 4
SIMVASTATIN 459 336 6 3
OMEPRAZOLE 386 217 7 6
POTASSIUM CHLORIDE 340 255 8 16
GABAPENTIN 302 144 9 15
PRAVASTATIN SODIUM 281 243 10 14
CARVEDILOL 277 142 11 21
METFORMIN HCL 241 151 12 8
GLIMEPIRIDE 226 143 13 34
ATORVASTATIN CALCIUM 223 158 14 11
ALLOPURINOL 222 166 15 31
METOPROLOL TARTRATE 218 153 16 9
CRESTOR 216 143 17 27
WARFARIN SODIUM 214 142 18 10
METOPROLOL SUCCINATE 207 172 19 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 192 123 20 33
HYDROCHLOROTHIAZIDE 187 133 21 12
CLOPIDOGREL 186 139 22 29
NEXIUM 175 81 23 28
RANITIDINE HCL 171 94 24 44
ISOSORBIDE MONONITRATE ER 169 123 25 40
ATENOLOL 168 114 26 17
PANTOPRAZOLE SODIUM 165 110 27 30
SERTRALINE HCL 163 145 28 22
GEMFIBROZIL 157 84 29 105
SPIRIVA 157 91 29 59
PAROXETINE HCL 155 101 31 69
LOSARTAN POTASSIUM 154 150 32 18
MELOXICAM 149 84 33 37
FLUOXETINE HCL 143 77 34 45
CIPROFLOXACIN HCL 142 100 35 62
SPIRONOLACTONE 139 91 36 57
PROAIR HFA 136 31 37 56
ZOLPIDEM TARTRATE 128 64 38 23
TRAMADOL HCL 127 87 39 20
DIGOXIN 124 109 40 61
PLAVIX 123 92 41 51
ROPINIROLE HCL 116 63 42 74
DICLOFENAC SODIUM 114 91 43 139
JANTOVEN 113 43 44 235
METFORMIN HCL ER 111 58 45 64
ADVAIR DISKUS 110 65 46 50
PEN NEEDLE 110 50 46 103
LYRICA 107 24 48 98
TRAZODONE HCL 107 82 48 39
DONEPEZIL HCL 106 106 50 24
NOVOLOG FLEXPEN 105 38 51 142
FENTANYL 103 62 S2 52 65
TAMSULOSIN HCL 103 66 52 26
LEVEMIR FLEXPEN 96 27 54 155
BENAZEPRIL HCL 93 81 55 85
PROMETHAZINE HCL 92 26 R 56 97
OXYCODONE HCL-ACETAMINOPHEN 87 32 S2 57 86
BUMETANIDE 87 57 57 131
CYCLOBENZAPRINE HCL 86 33 R 59 63
LANTUS SOLOSTAR 86 42 59 91
NAPROXEN 83 39 61 104
DILTIAZEM 24HR ER 83 60 61 122
FAMOTIDINE 81 56 63 55
BUSPIRONE HCL 80 48 64 124
ACTOS 80 39 64 149
LANTUS 78 40 66 38
DIOVAN 77 72 67 49
TRIAMTERENE-HCTZ 76 67 68 42
CEFDINIR 76 52 68 210
SINGULAIR 75 36 70 90
FLUTICASONE PROPIONATE 72 51 71 46
CITALOPRAM HBR 72 43 71 19
NAMENDA 71 58 73 32
TORSEMIDE 70 53 74 126
MECLIZINE HCL 69 40 75 146
BACLOFEN 68 12 76 125
AMLODIPINE BESYLATE-BENAZEPRIL 68 66 76 83
METHYLPREDNISOLONE 67 46 78 138
PROPRANOLOL HCL 67 40 78 129
LOSARTAN-HYDROCHLOROTHIAZIDE 67 67 78 53
KLOR-CON M20 66 49 81 48
NOVOLOG 66 34 81 81
VERAPAMIL ER 66 63 81 119
CLONIDINE HCL 64 24 84 60
CEPHALEXIN 64 27 84 70
THEOPHYLLINE ANHYDROUS 63 50 86 219
ALPRAZOLAM 63 47 86 145
TOPIRAMATE 62 0 88 152
LIPITOR 61 40 89 114
POLYETHYLENE GLYCOL 3350 61 21 89 43
ALENDRONATE SODIUM 60 52 91 25
PREDNISONE 60 38 91 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 35 91 95
SYMBICORT 60 42 91 157
CELEBREX 59 52 95 93
VENLAFAXINE HCL ER 58 31 96 100
OXYBUTYNIN CHLORIDE 58 33 96 96
OLANZAPINE 55 23 98 108
IBUPROFEN 55 0 98 115
KLOR-CON M10 54 38 100 137
METOCLOPRAMIDE HCL 54 29 100 121
ESCITALOPRAM OXALATE 53 33 102 54
CYMBALTA 53 14 102 35
AZITHROMYCIN 52 32 104 41
FENOFIBRATE 52 42 104 66
RAMIPRIL 52 41 104 113
HYDROXYZINE HCL 51 21 R 107 165
MONTELUKAST SODIUM 51 29 107 160
DOXYCYCLINE HYCLATE 50 22 109 112
DILTIAZEM ER 50 50 109 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.